SiTime Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? SiTime Corporation trades at $592 (market cap $16.63B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, SiTime Corporation nearer its low. Which is the better fit depends on your goals.
| SITM | XBI | |
|---|---|---|
Market Cap | $16.63B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $901.60 | $164.28 |
52-Week Low | $190.16 | $85.16 |
Enterprise Value | $15.84B | — |
Trailing returns across standard periods
Latest headlines on both assets
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →